Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096597 · ClinicalTrials.gov registry record · Phase 2
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
A Phase 2 study of Interstitial Cystitis and Painful Bladder Syndrome, sponsored by David Sheyn.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06096597 is a Phase 2 study of Interstitial Cystitis and Painful Bladder Syndrome that is actively recruiting participants, run by David Sheyn. The registered enrollment target is 100 participants, below the 358-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06096597, a Phase 2 study of Interstitial Cystitis and Painful Bladder Syndrome, is actively recruiting participants, sponsored by David Sheyn.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary frequency and urgency. The primary objective of this study is to determine the efficacy of amniotic membrane therapy in patients with interstitial cystitis/painful bladder syndrome (IC/PBS) as defined by clinically-significant improvement in validated symptom questionnaires.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Clarix Flo
Study Locations (1)
Ohio
- University Hospitals - Clevleand
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07-24 |
| Est. Completion | 2026-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06096597
The ClinicalTrials.gov registry entry for NCT06096597 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (72% lower). The listed sponsor is David Sheyn, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06096597 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06096597 about?
NCT06096597 is a clinical study titled "Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome". Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary frequency and urgency. The primary objective of this study is to determine the efficacy of amniotic...
What is the current status of trial NCT06096597?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2024-07-24. Estimated completion is 2026-06.
What conditions does trial NCT06096597 study?
This clinical trial studies the following conditions: Interstitial Cystitis, Painful Bladder Syndrome, Painful Bladder Syndrome (PBS).
What interventions are being tested in trial NCT06096597?
The interventions under investigation include: Placebo (DRUG), Clarix Flo (DRUG).
Who is sponsoring clinical trial NCT06096597?
This trial is sponsored by David Sheyn, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06096597 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
RECRUITING · Phase 2
-
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
RECRUITING · Phase 2
-
Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC
COMPLETED · Phase 2
-
Study of U101 for Bladder Pain and/or Urgency
COMPLETED · Phase 2
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.